First Metatarsalphalangeal Joint Arthrodesis in Rheumatoid Arthritis: A Case Report of Non-Union

Abstract

The Foot & Ankle Journal 1 (4): 3The author presents a case report of Case ReportA 35 year old female with a history of rheumatoid arthritis presented to the podiatry clinic with a chief complaint of pain in the right great toe for the previous 6 months. Her systemic disease was adequately controlled by her primary physician with Etanercept (Enbrel ® ), 25 mg injected subcutaneously twice per week. The patient was also taking Alendronate (Foxamax ® )70mg by mouth weekly. We also prescribed naproxen, 500 mg twice per day, and hydrocodone, 5mg with acetaminophen 500 mg as needed for breakthrough pain. The patient's primary provider also prescribed a baseline daily dose of prednisone, 10 mg daily, in addition to an increase, then tapering schedule with an endpoint of 20 mg daily.